The global Pharmaceutical membrane filtration market is expected to grow from USD 5.8 billion in 2020 to USD 10.2 billion by 2025, at a CAGR of 12.0% from 2020 to 2025. The major factors driving the growth of this market are the increasing adoption of single-use technologies and the growing demand for nanofiltration.
The major players operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France). These players have adopted various growth strategies, such as product launches, partnerships & collaborations, and expansions to increase their presence in the global market.
Merck Millipore (Germany) is the leader in the global pharmaceutical membrane filtration market. The company prominently focuses on organic growth strategies such as product launches and acquisitions to strengthen its market position in the pharmaceutical membrane filtration market. Merck offers a wide range of innovative products in the pharmaceutical and biopharmaceutical industry. The company’s membrane filters are used for the separation and purification of APIs, biological samples, and buffers to obtain the highest quality results from downstream analysis. Merck’s wide range of membranes, filter holders, and related filtration devices are used to collect, separate, or remove contaminants from air or fluid samples prior to downstream analysis.
Danaher (US) is the second-largest player in the global pharmaceutical membrane filtration market. Pall Corporation, a subsidiary of Danaher, is involved in offering pharmaceutical filtration products. The company is a global leader in high-tech filtration, separation, and purification, serving the diverse needs of customers across the broad spectrum of the life sciences industry. The company offers a comprehensive portfolio of advanced filters that are used in the pharmaceutical and biopharmaceutical industry.
Phone : +1-888-600-6441
Email : firstname.lastname@example.org